Top

--Request for Information on Capabilities Available to Support the Department of Defense Critical Reagents Program

Active

USA-SNOTE-071220-006Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

The Department of Defense's Critical Reagents Program (CRP) issued a Request for Information (RFI) to gather insights from military and commercial entities regarding their capabilities in developing and producing biological detection assays and reagents. This RFI is purely for planning purposes and does not imply any commitment or payment by the Government, nor does it guarantee a subsequent solicitation. The CRP focuses on supplying validated, high-quality assays and reagents, such as antibody-based lateral flow immunoassays, electrochemiluminescence assays, and PCR assays, which detect Category A and B biological warfare agents. These products support a wide range of defense needs, including the Joint Biological Point Detection System, Joint Portal Shield system, and other kits used for domestic preparedness, counter-terrorist operations, and other government agency activities. The program also manages the manufacturing, storage, distribution, and quality assurance processes required for these critical reagents. The Government seeks detailed information from respondents about their technological and manufacturing competencies in areas like PCR and nucleic acid detection, antibody-based detection, multiplex assay technologies, production capacity, quality control testing, and cold chain product management. Respondents are invited to provide comprehensive supporting documentation, including product data sheets, commercial practices, lead times, quality control measures, independent testing results, warranty terms, and customer service capabilities. The information collected will aid the Government in better understanding available commercial capabilities and improving the CRP’s supply chain and technology transition efforts. Responses were requested by January 31, 2008, with submissions preferred electronically, and proprietary information must be clearly identified. Material solely promotional in nature will not be accepted.

General Info

DoD seeks information on capabilities for biological detection assays and reagents development.

Agency

Department Of Defense → W6QK Acc-Rsa

NAICS

325413 - In-Vitro Diagnostic Substance Manufacturing

Place of Performance

Set-Aside

NONE

Documents

No documents available

Documents will appear here when they are available.

AI Contract Breakdown

Uniform Contract Format

No documents to break down

The breakdown needs solicitation documents. None were found from this contract's source.

Timeline

PostedDec 20

special-notice

Ready to pursue this opportunity?

Get full access to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

AgencyDepartment Of Defense → W6QK Acc-Rsa

ContactsNo contacts available

OfficeREDSTONE ARSENAL, AL, 35898-5000, USA

Organization / AgencyDepartment Of Defense → W6QK Acc-Rsa

Office AddressREDSTONE ARSENAL, AL, 35898-5000, USA

ContactsNo contact information available

Full Description

This is a Request for Information (RFI) for planning purposes only. It is not to be construed as a commitment by the Government nor will the Government pay for the information solicited. No solicitation document exists or is guaranteed to be issued as a result of this RFI. The Critical Reagents Program (CRP) is seeking information on the capabilities of various military and commercial entities in the areas listed below. The CRP's mission is to serve as the principle resource of high quality, valid ated, and standardized biological detection assays and reagents that meet the requirements of the Warfighter and Joint biological defense community by facilitating the transition of new technologies and coordinating their advanced development, efficient pr oduction and timely distribution. The CRP supports manufacture, storage and distribution of consumable reagents and end items for the Biological Defense Joint Biological Point Detection System (JBPDS) and the Joint Portal Shield (JPS) System, as well as o ther assays (e.g., Hand Held Assys [HHA] and sampling kits (e.g. Biological Sampling Kit [BSK] used for domestic preparedness, Homeland Defense, counter-terrorist operations and by Other Government Agencies (OGA). The CRP maintains multiple repositories f or the storage and distribution of CRP products. The CRP supplies Government and private test laboratories with antibodies, antigens, and genomics that are used for basic research, assay development and validation. The CRP manages production of reagents and manufacture of assays to meet the needs of the Defense community. The CRP produces two types of antibody-based assays (i.e., lateral flow immunoassays and electrochemiluminescence assays) for the detection of Category A and B biological warfare agents (BWAs). The CRP also supplies Polymerase Chain Reaction (PCR) assays for detecting BWAs. Together, these products afford front-line Warfighters or First Responders the capability to test environmental samples for the presence of selected BWAs. The Gove rnment is interested in receiving information from qualified companies in the following areas: (1) PCR and nucleic acid detection technologies, (2) antibody-based detection technologies, (3) lateral flow immunoassay technologies, (4) manufacturing capabili ties to support production of detection assays and kits, (5) multiplexing technology of molecular and /or antibody based assays, (6) conformance/quality control testing, and (7) storage and distribution of products in accordance with Cold Chain Management requirement and Center for Disease Control Laboratory Registration and Select Agent Transfer Program. Respondents are invited to provide reading materials related to best commercial practices, quality system, product/service technical descriptions (i.e. p roduct data sheets), length of time product/service has been provided, product samples, cost drivers in manufacture of product; number, size, location of suppliers; production capability to meet requirements and how commercial sales may effect; packaging, handling, storage and transportation practices; quality controls and statistical process controls; lead times for key components; training available at site; technical data package availability; stability of current configuration/technology, lists of simil ar users using products and the DoD environment; independent test results from test organizations; minimum order quantities; typical contract terms; warranty; and customer service capability. The Government will retain comments and information received in response to this RFI. Proprietary information should be identified as Company Proprietary. Do not use Government Security classification markings. All written responses must be received by January 31, 2008. Responses should be addressed to the Govern ment Contract Specialist Leo Fratis: contact@example.gov. Respondents shall designate a company point of contact for the Government. Preferred media is ele ctronic (i.e. Microsoft Word, Portable Document Format, or MS Power Point) via e-mail submission. However, other media types (i.e. CD, printed technical information( will be accepted and should be sent to US Army Space & Missile Defense Command, ATTN: Leo Fratis, 64 Thomas Johnson Drive, Frederick, Maryland 21702. Material that is advertisement only in nature is not desired.